Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in chronic hepatitis C (roll-over from C216)
NCT01054573Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Johnson & Johnson. Started Apr 2010; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01054573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01054573.